Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients

NCT02796261 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

343

Enrollment

INDUSTRY

Sponsor class

Conditions

Anaplastic Astrocytoma
Recurrent Anaplastic Astrocytoma

Interventions

DRUG: Eflornithine
DRUG: Lomustine
DRUG: Lomustine

Sponsor

Orbus Therapeutics, Inc.